cGMP MANUFACTURING

Cell Banking

Northway Biotechpharma provides cGMP Master and Working Cell Banks (MCB/WCB) to support your long-term manufacturing needs.

We characterize cell banks according to all applicable ICH guidelines, employing testing methods specific to the cell line used for your production. Cells are grown in the appropriate incubators, and microbial and mammalian cell banking activities are conducted in completely separate areas. We certify that mammalian cell lines are free of mycoplasma and bacterial contamination.

For risk mitigation, we store a portion of our clients’ MCBs and WCBs offsite under cGMP conditions, either in vapor phase of liquid nitrogen vessels or in deep freezers (-80º C), with a monitoring system to confirm proper liquid nitrogen levels and freezer temperatures at all times. Banks are separated and stored in individual freezers at two different locations to prevent loss due to freezer malfunction, and a fully redundant backup system ensures security of the storage facility.


Cell Banking Capabilities

  • Master and working cell bank manufacturing for mammalian and microbial cultures
  • Characterization and testing of MCBs and WCBs according to ICH Q5B, Q5D, Q5A, Q6B and Q7 guidelines
  • Aseptic cell banking within certified laminar flow II biosafety level cabinets with Class A high-efficiency particulate air (HEPA)
  • Stability studies

cGMP MANUFACTURING

Drug Substance

With industry-leading expertise and state-of-the-art single-use equipment, we can take your API from concept to commercialization, all within our modern facilities

Learn More

cGMP MANUFACTURING

Drug Product

From formulation development to sterile fill-finish, Northway Biotechpharma supports your product’s development through every step of the journey.

Learn More